CJ to invest $2.5 million in Neuralstem Inc.

CJ CheilJedang Corporation, a subsidiary company of CJ Group, said on February 20 that it has purchased an option to negotiate for the exclusive license to Neuralstem's stem cell-products and technology after the company completes a successful human clinical trial.

Neuralstemi is a U.S. company biopharmaceutical company with a robust and diverse development pipeline derived from its novel an...